Micro-Tech Nanjing Co

Micro-Tech Nanjing Co EBIT per Share

The EBIT per Share of Micro-Tech Nanjing Co (688029.SS) as of Oct 21, 2026 is 3.72 CNY. In the previous year, EBIT per Share was 3.50 CNY — a change of 6.47% (higher).

EBIT per Share

3.72CNY

YoY

6.47%

Last updated:

EBIT per Share of Micro-Tech Nanjing Co is 2025 3.72 CNY. EBIT per Share of Micro-Tech Nanjing Co was 2024 3.50 CNY. It decreases by 6.47% higher compared to the previous year.

The Micro-Tech Nanjing Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
1.92 CNY
Jan 1, 2022
1.91 CNY
Jan 1, 2023
2.96 CNY
Jan 1, 2024
3.50 CNY
Jan 1, 2025
3.72 CNY
Jan 1, 2026 (e)
3.68 CNY
Jan 1, 2027 (e)
4.33 CNY
Jan 1, 2028 (e)
5.37 CNY
The Micro-Tech Nanjing Co EBIT per Share history
YEAREBIT per ShareYoY
est5.37CNY+24.03%
est4.33CNY+17.87%
est3.68CNY-1.23%
3.72CNY+6.47%
3.50CNY+18.22%
2.96CNY+54.66%
1.91CNY-0.32%
1.92CNY+20.26%
1.60CNY-16.33%
1.91CNY+12.83%
1.69CNY+79.56%
0.94CNY-1,318.12%
-0.08CNY-136.64%
0.21CNY+26.20%
0.17CNY+46.69%
0.11CNY-53.63%
0.25CNY-4.96%
0.26CNY+22.76%
0.21CNY+86.24%
0.11CNY+34.14%
0.08CNY+97.19%
0.04CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Micro-Tech Nanjing Co Stock analysis

What does Micro-Tech Nanjing Co do? Micro-Tech (Nanjing) Co., Ltd. generates revenue through the sale of medical equipment, including three series of endoscopic diagnosis and treatment instruments, microwave ablation equipment, and disposable endoscopes. The company's main products consist of biopsy, hemostasis, and closure tools, Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD) systems, dilation devices, and Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasonography (EUS), and Endobronchial Ultrasound (EBUS) equipment. Microwave ablation products include instruments and needles, while disposable endoscopes feature a disposable biliopancreatic imaging system (choledochoscope) and related consumables. These products are sold to healthcare providers and medical facilities globally. The company's endoscopic diagnosis and treatment instruments target hospitals and clinics specializing in gastrointestinal and respiratory procedures, where EMR, ESD, ERCP, EUS, and EBUS procedures are commonly performed. Microwave ablation equipment is primarily purchased by oncology departments for tumor treatment, while disposable endoscopes are used in minimally invasive procedures requiring single-use tools. These segments focus on improving patient outcomes through advanced diagnostic and therapeutic solutions. Micro-Tech (Nanjing) Co., Ltd. serves medical professionals seeking reliable, high-quality equipment for endoscopic procedures, with a strong emphasis on disposable and reusable systems that enhance safety and efficiency. The firm's product portfolio aligns with global healthcare trends toward minimally invasive treatments and cost-effective medical solutions. By offering comprehensive endoscopic and ablation systems, the company meets the needs of healthcare providers across multiple specialties and regions. Micro-Tech Nanjing Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Micro-Tech Nanjing Co stock

EBIT per Share of Micro-Tech Nanjing Co is 3.72 CNY in 2025.

EBIT per Share of Micro-Tech Nanjing Co changed from 3.50 CNY to 3.72 CNY, representing a 6.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Micro-Tech Nanjing Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Micro-Tech Nanjing Co

All Key Metrics — Micro-Tech Nanjing Co